Loss of Endocan tumorigenic properties after alternative splicing of exon 2

Loss of Endocan tumorigenic properties after alternative splicing of exon 2

<p>Abstract</p> <p>Background</p> <p>Endocan was originally described as a dermatan sulfate proteoglycan found freely circulating in the blood. Endocan expression confers tumorigenic properties to epithelial cell lines or accelerate the growth of already tumorigenic cel...

Full description

Bibliographic Details
Main Authors: Scherpereel Arnaud, Grigoriu Bogdan-Dragos, Depontieu Florence, Adam Estelle, Delehedde Maryse, Gosset Philippe, Lassalle Philippe
Format: Article
Language:English
Published: BMC 2008-01-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/8/14

Internet

http://www.biomedcentral.com/1471-2407/8/14

Similar Items